Abstract:Abstract Background: Forkhead box protein H1 (FOXH1) is upregulated in a variety of cancer types but its expression patterns and specific functions in lung cancer are unclear at present. The main objective of the present study was to establish whether FOXH1 plays a role in regulation of lung cancer progression. Methods: The TCGA and Kaplan-Meier plotter dataset was analyzed for possible association between FOXH1 expressions in lung cancer tissues and patient prognosis. A549 and PC9 cells were transfected with shRNA targeting FOXH1 mRNA. The Cell Counting Kit-8 (CCK8), plate clone formation, soft agar, wound healing, transwell invasion and flow cytometry assay were performed to detect the cell proliferation, migration and invasion in lung cancer cells. Tumorigenicity was examined in mouse model system. Western blot analysis was used to detect FOXH1, Matrix metalloproteinase 2 (MMP2), Vimentin, N-cadherin, E-cadherin, Snail, Slug, p-GSK-3β, β-catenin and Cyclin D1. The β-catenin activity was measured by luciferase reporter system assay. Results: FOXH1 expression in the lung cancer was determined using the TCGA and Kaplan-Meier plotter databases. Higher expression of FOXH1 was observed in tumor tissue relative to normal tissue, which was associated with reduced overall survival. FOXH1 knockdown resulted in significant inhibition of the proliferation, the cell cycle, the migration as well as the invasion of lung cancer cells. Then, we confirmed that FOXH1 knockdown can significantly slow down tumor growth and tumor cell proliferation in vivo using the mouse model. It also significantly reduced the migration and invasion capabilities of lung cancer cells. Using Western blot analyses, we found that FOXH1 depletion inhibited the epithelial-mesenchymal transition of lung cancer cells through downregulation of the mesenchymal cell markers Snail, Slug, MMP2, N-cadherin, and Vimentin, and upregulation of the epithelial marker E-cadherin. Moreover, FOXH1 knockdown significantly downregulated β-catenin and its downstream targets, such as p-GSK-3β and cyclin D1, and also led to direct suppression of β-catenin activity, as determined by the luciferase reporter system assay. Conclusion: In conclusion, FOXH1 promotes proliferation, migration, and invasion of lung cancer cells via regulation of Wnt/β-catenin signaling. FOXH1 is a prognostic marker and a potential therapeutic target for lung cancer treatment.

HUWE1 Controls the Development of Non-Small Cell Lung Cancer Through Down-Regulation of P53

Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation And Tumor Growth Through The Histone H1.3-H19 Cascade

The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.

P53-regulated Long Non-Coding RNA TUG1 Affects Cell Proliferation in Human Non-Small Cell Lung Cancer, Partly Through Epigenetically Regulating HOXB7 Expression.

HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.

Wilms’ tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway

Pd-L1 Promotes Tumor Growth And Progression By Activating Wip And Beta-Catenin Signaling Pathways And Predicts Poor Prognosis In Lung Cancer

p53 negatively regulates Wnt pathway and inhibits the proliferation and invasion of lung cancer cell

FOXH1 Promotes Lung Cancer Progression by Activating the Wnt/β-catenin Signaling Pathway

FOXH1&nbsp;Promotes Tumor Growth and Metastasis via Regulation of Wnt/β-catenin Signaling Pathway in Lung Cancer&nbsp;

LUCAT1 Activates the Malignant Phenotypes of Lung Cancer Cells Via Regulating P53 Ubiquitination.

FOXH1 Promotes Tumor Growth and Metastasis via Regulation of Wnt/β-catenin Signaling Pathway in Lung Cancer

PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer

E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation

WT1‐interacting Protein Inhibits Cell Proliferation and Tumorigenicity in Non‐small‐cell Lung Cancer Via the AKT/FOXO1 Axis

The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression

HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin–proteasome pathway (Biochemical and Biophysical Research Communications, v. 444, isse 4)

Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation

MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells

UHMK1 Promotes Lung Adenocarcinoma Oncogenesis by Regulating the PI3K/AKT/mTOR Signaling Pathway

PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer